Search for the latest updates on diabetes
News
Type 2 Diabetes: Investigational empagliflozin/linagliptin combination tablet shows sustained reduction in blood ... Business Wire via Yahoo! Finance - 10 minutes
INGELHEIM, Germany & INDIANAPOLIS--(BUSINESS WIRE)-- Boehringer Ingelheim and Eli Lilly and Company today presented results from a 52-week ...
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment